Cadrenal Therapeutics, Inc. 424B5 Filing

From the Filing

EDGAR Filing Documents for 0001213900-26-038010 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 424B5 - Prospectus [Rule 424(b)(5)]: SEC Accession No. 0001213900-26-038010 Filing Date 2026-04-01 Accepted 2026-04-01 07:30:38 Documents 1 Document Format Files Seq Description Document Type Size 1 PROSPECTUS SUPPLEMENT ea0284523-424b5_cadrenal.htm 424B5 6992 Complete submission text file 0001213900-26-038010.txt 8016 Mailing Address 822 A1A NORTH SUITE 306 PONTE VEDRA FL 32082 Business Address 822 A1A NORTH SUITE 306 PONTE VEDRA FL 32082 904-300-0701 Cadrenal Therapeutics, Inc. (Filer) CIK : 0001937993 (see all company filings) EIN. : 880860746 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 424B5 | Act: 33 | File No.: 333-283226 | Film No.: 26824702 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)